GSK Is ‘Betting Big’ on the US, CEO Walmsley Says

GSK is “betting big on the US” and engaged in "constructive" talks on drug pricing with President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer of the British drugmaker. Pfizer Inc.'s pricing deal with Trump is a “step forward and it’s progress,” Wal...

Redirecting to full article...